Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Morgan Stanley reported a 7.70% stake in Apellis Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 3, 2025
Morgan Stanley reported a 7.70% stake in Apellis Pharmaceuticals, Inc., 9,592,751 shares, as a passive investor on Dec 31, 2024. Filed Feb 3, 2025 (Schedule 13G).
- Stake
- 7.70%
- Shares
- 9,592,751
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 7.70% | 9,592,751 |
| Morgan Stanley Capital Services LLC | 6.30% | 7,803,185 |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Morgan Stanley
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026
- Form 4 · Dolsten Mikael · May 14, 2026